Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinshuibao for chronic kidney disease due to primary glomerulonephritis
ChiCTR2000031731Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of fermented cordyceps sinensis mycelia powder in chronic kidney disease (CKD) and primary glomerulonephritis (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Change from baseline in estimated glomerular filtration rate. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
fermented cordyceps sinensis mycelia powder
03
Conditions
chronic kidney disease (CKD)primary glomerulonephritis
Beyond the preview
Go deeper on ChiCTR2000031731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031731.